NHS Faces Protests and Complaints Against Palantir Data Platform
NHS staff and patients protest and file complaints against Palantir over privacy issues.
Why it matters: Patient trust is crucial for effective healthcare, and data privacy issues could undermine it, posing legal risks for providers.
- NHS signed a £330M contract with Palantir for a data platform in 2023.
- By 2026, only 151 of 240 NHS bodies adopted the platform.
- Over 47,000 patient letters opposed the platform's use by NHS trusts.
- BMA advised limiting platform use due to data privacy concerns.
The NHS is facing protests and formal complaints from staff and patients over its engagement with Palantir's data platform. This comes after the NHS signed a £330 million contract in 2023 to utilize Palantir’s technology aimed at linking patient and operational data across various bodies.
Despite the investment, only 151 out of 240 NHS bodies have adopted the Palantir platform by early 2026, highlighting substantial resistance. The apprehension centers around privacy issues, partly linked to Palantir's past ties with U.S. surveillance efforts and the implications of the U.S. CLOUD Act, which raises concerns about data stored in the UK being accessed.
The British Medical Association (BMA) has recommended that healthcare providers limit the use of the platform due to these privacy concerns. This stance is reinforced by over 47,000 letters from patients opposing the technology's implementation, indicating significant public distrust.
For NHS legal and compliance teams, the balancing act involves integrating cutting-edge data solutions while safeguarding patient information and preserving trust. The issue also reflects a broader context, with other places such as New York City reassessing similar agreements with Palantir due to ongoing security concerns.
By the numbers:
- £330M — Value of NHS contract with Palantir in 2023.
- 151 — Total NHS bodies out of 240 that adopted the platform by 2026.
- 47,000+ — Patient letters opposing the platform's use.
Yes, but: Although significant opposition exists, the platform promises vital advancements in healthcare data management.
What's next: Ongoing evaluations of Palantir's platform by NHS may result in policy revisions by late 2026.